These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36838590)

  • 1. Identification of the Putative Binding Site of a Benzimidazole Opioid (Etazene) and Its Metabolites at µ-Opioid Receptor: A Human Liver Microsomal Assay and Systematic Computational Study.
    Chaturvedi K; Hewamanna I; Pandey P; Khan W; Wang YH; Chittiboyina AG; Doerksen RJ; Godfrey M
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMS.
    Verougstraete N; Verhaeghe A; Germonpré J; Lebbinck H; Verstraete AG
    Drug Test Anal; 2023 Feb; 15(2):235-239. PubMed ID: 36181239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etazene induces developmental toxicity in vivo Danio rerio and in silico studies of new synthetic opioid derivative.
    Kurach Ł; Chłopaś-Konowałek A; Budzyńska B; Zawadzki M; Szpot P; Boguszewska-Czubara A
    Sci Rep; 2021 Dec; 11(1):24269. PubMed ID: 34931035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework.
    Grafinger KE; Wilde M; Otte L; Auwärter V
    Forensic Sci Int; 2021 Oct; 327():110989. PubMed ID: 34509061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
    Sader S; Anant K; Wu C
    Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of
    Kapoor A; Provasi D; Filizola M
    Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β
    Wtorek K; Lipiński PFJ; Adamska-Bartłomiejczyk A; Piekielna-Ciesielska J; Sukiennik J; Kluczyk A; Janecka A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
    Wang H; Reinecke BA; Zhang Y
    J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Nilsen A; Torralva R; Janowsky A
    Biochem Pharmacol; 2020 Dec; 182():114293. PubMed ID: 33091380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.
    Xie B; Goldberg A; Shi L
    Comput Struct Biotechnol J; 2022; 20():2309-2321. PubMed ID: 35615021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor.
    Deventer MH; Persson M; Laus A; Pottie E; Cannaert A; Tocco G; Gréen H; Stove CP
    Arch Toxicol; 2023 May; 97(5):1367-1384. PubMed ID: 36853332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designer Benzodiazepines' Activity on Opioid Receptors: A Docking Study.
    Catalani V; Botha M; Corkery JM; Guirguis A; Vento A; Schifano F
    Curr Pharm Des; 2022; 28(32):2639-2652. PubMed ID: 35538798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking.
    Dumitrascuta M; Bermudez M; Trovato O; De Neve J; Ballet S; Wolber G; Spetea M
    Molecules; 2021 May; 26(11):. PubMed ID: 34071603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.
    Noha SM; Schmidhammer H; Spetea M
    ACS Chem Neurosci; 2017 Jun; 8(6):1327-1337. PubMed ID: 28125215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.
    Vekariya RH; Lei W; Ray A; Saini SK; Zhang S; Molnar G; Barlow D; Karlage KL; Bilsky EJ; Houseknecht KL; Largent-Milnes TM; Streicher JM; Ananthan S
    J Med Chem; 2020 Jul; 63(14):7663-7694. PubMed ID: 32530286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine.
    Wang HY; Burns LH
    PLoS One; 2009; 4(1):e4282. PubMed ID: 19172190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of N-desethyl etonitazene in a drug checking sample: Chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole "nitazene" class.
    Monti MC; De Vrieze LM; Vandeputte MM; Persson M; Gréen H; Stove CP; Schlotterbeck G
    J Pharm Biomed Anal; 2024 Dec; 251():116453. PubMed ID: 39216307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
    Vandeputte MM; Cannaert A; Stove CP
    Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-substituted tetrahydro-beta-carboline as mu-opioid receptors ligands: in silico study; molecular docking, ADMET and molecular dynamics approach.
    Alananzeh WA; Al-Qattan MN; Ayipo YO; Mordi MN
    Mol Divers; 2024 Jun; 28(3):1273-1289. PubMed ID: 37133710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.